A 40-year-old woman from a lower socio-economic background in Mysuru, diagnosed with bipolar disorder for 25 years, could continue her psychiatric treatment because she received Rs 2,000 a month under Karnataka’s Gruha Lakshmi scheme. That single line from a case study published in the Digital Journal of Clinical Medicine should reframe how India evaluates welfare.
The study by JSS Academy does not argue that cash transfers cure mental illness. Her psychotropic costs alone were Rs 1,000 a month — half her entitlement. What it shows is that treatment adherence is not just a clinical problem; it is an economic one. Severe mental illness disproportionately hits women who are homemakers, married for 22 years into a daily-wage household, with compounded vulnerabilities of economic dependence, limited workforce participation and caregiving burdens.
Policy discourse in India treats mental health as a tertiary hospital issue and welfare as a political freebie. This case collapses that binary. The Rs 2,000 did not go to a pharmacy directly; it freed up household fiscal space stressed by financial anxiety — the very trigger that worsened her condition. In other words, Gruha Lakshmi acted as an enabler of health access.
As the report notes, mental disorders are a major global public health challenge. For India, where out-of-pocket expenditure remains the biggest barrier to psychiatric care, women-centric direct benefit transfers may be the most under-rated mental health intervention. It is time to audit guarantees not just for votes, but for vital signs